Fierce Pharma September 25, 2024
As private equity firms reportedly place their bids, Sanofi may soon follow in the footsteps of GSK and Johnson & Johnson with the separation of its consumer health unit.
Sanofi has received separate offers from private equity firms PAI Partners and Clayton, Dubilier & Rice for its consumer health business, which could be valued at 15 billion euros ($16.7 billion) or more, Bloomberg reported Tuesday, citing people close to the matter.
Sanofi will likely make a decision on the fate of its consumer health unit in the coming days, Bloomberg’s sources said. Sanofi could pursue a spinoff if the proposed deals fall short, the anonymous sources added.
PAI and Clayton, Dubilier & Rice were both singled out as potential buyers...
Today's Sponsors
Today's Sponsor